Status:
UNKNOWN
Photodynamic Therapy (PDT) Cholangiocarcinoma Registry
Lead Sponsor:
Weill Medical College of Cornell University
Conditions:
Unresectable Cholangiocarcinoma
Biliary Obstruction
Eligibility:
All Genders
18+ years
Brief Summary
Currently, very few centers offer Photodynamic therapy for unresectable Cholangiocarcinoma in the United States. Several European studies have reported the efficacy and safety of Photodynamic Therapy ...
Detailed Description
PDT offers a number of practical advantages; it is minimally invasive and has a low complication rate, the procedure can easily be performed by a trained endoscopist, and it is well tolerated. In the ...
Eligibility Criteria
Inclusion
- Any patient who is undergoing PDT for unresectable Cholangiocarcinoma
- Above 18 years of age
Exclusion
- Any patient who will not undergo PDT for unresectable Cholangiocarcinoma
- Below 18 years of age
Key Trial Info
Start Date :
November 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 30 2018
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT01524146
Start Date
November 1 2011
End Date
December 30 2018
Last Update
February 20 2017
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Weill Cornell Medical College
New York, New York, United States, 10021
2
Weill Medical College of Cornell University
New York, New York, United States, 10021